FindMyKOL
Clinical trialNCT05506449TerminatedInterventional

The RECOVER IV Trial

SponsorAbiomed Inc.Enrollment4Cardiogenic ShockST-segment Elevation Myocardial Infarction (STEMI)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess whether hemodynamic support with an Impella-based treatment strategy initiated prior to percutaneous coronary intervention (PCI) in patients with ST-Segment Elevation Myocardial Infarction (STEMI)-Cardiogenic Shock (CS) improves survival and functional outcomes compared to a non-Impella-based treatment strategy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Rigshospitalet Copenhagen

    Copenhagen, Denmark

Germany
  • Herzzentrum Dresden

    Dresden, Saxony, Germany

  • University Hospital Düsseldorf

    Düsseldorf, Germany

  • Universitatsklinikum Schleswig Holstein

    Kiel, Germany

  • Krankenhaus Der Barmherzigen Brüder Trier

    Trier, Germany

Switzerland
  • Inselspital Bern

    Bern, Switzerland

United States
  • New Mexico Heart Institute

    Albuquerque, New Mexico, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Oct 2023
Primary completion
10 May 2024
Completion
6 Dec 2024
Last update posted
29 Jan 2025
Registered enrollment
4
Registry id
NCT05506449

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.